The manufacturing unit of a major pharmaceutical company located at Virgonagar in Bangalore has violated the norms for scientific disposal of effluent.
India is taking steps to reverse anti-counterfeiting measures in some east African nations that could stop the importation of generic drugs made in the country.
THE DELHI High Court on Monday referred six drug patent cases to the Intellectual Property Appellate Board (IPAB), the apex government body to hear such disputes. This could set a precedent for all future appeals regarding `pre-grant
By opening up its database of potential malaria drugs, GlaxoSmithKline has blazed a path that other pharmaceutical companies should follow. (Editorial)
The turf war between the pharmaceutical industry and Drug Controller General of India (DCGI) is set to intensify after sources close to DCGI confirmed on Monday that the drug controller will soon be approaching the Supreme Court over the issue of centralising power to grant Certificate of Pharmaceutical Products (CoPP)